Gemcitabine and cisplatin or oxaliplatin chemotherapy combined with atezolizumab plus bevacizumab for advanced biliary tract cancers: a single-arm trial Supplementary Table 1

This work was supported by the Clinical Research Plan of SHDC (no. SHDC2020CR1004A), the State Key Program of National Natural Science Foundation of China (no. 81730097), the National Natural Science Foundation of China (no. 82072618) and the Science and Technology Commission Foundation of Shanghai Municipality (no. 19411967300). The fundings have no roles in the design of the study or collection, analysis and interpretation of data or in writing the manuscript. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.